• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec18
Femasys Inc. Obtains FDA Approval for FemVue Controlled Device
14:15
Nov15
Femasys released FY2025 9 Months Earnings on November 14, 2025 (EST) with actual revenue of USD 1.48 M and EPS of USD -0.4955
04:00
Femasys released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 729.39K (forecast USD 1.35M), actual EPS USD -0.1022 (forecast USD -0.115)
04:00
Nov3
Femasys Inc. Obtains FDA Approval to Commence Recruitment for FINALE Trial's Final Stage
13:30
Aug9
Femasys released FY2025 Semi-Annual earnings on August 8 (EST), actual revenue USD 750.53K, actual EPS USD -0.3878
03:00
Femasys released FY2025 Q2 earnings on August 8 (EST), actual revenue USD 409.27K (forecast USD 1.169M), actual EPS USD -0.16 (forecast USD -0.1625)
03:00

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 729.39 K, Net Income -4.195 M, EPS -0.1022

Aug8
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 409.27 K, Net Income -4.586 M, EPS -0.1587

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 341.26 K, Net Income -5.897 M, EPS -0.2344

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LAZR
0.6044
+174.73%
+0.384
NBY
5.300
+79.66%
+2.350
MIMI
0.4795
+75.45%
+0.206
AZI
2.500
+64.47%
+0.980
GDC
5.260
+51.59%
+1.790
SOS
2.200
+47.65%
+0.710
IBO
0.6491
+46.26%
+0.205
FLYT
17.130
+45.42%
+5.350
CRWG
3.950
+45.22%
+1.230
CRWU
7.290
+44.93%
+2.260
View More